메뉴 건너뛰기




Volumn 93, Issue 3, 2010, Pages 880-884

Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PRASTERONE SULFATE; THYROXINE; TRIACYLGLYCEROL;

EID: 75749115194     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.10.058     Document Type: Article
Times cited : (54)

References (22)
  • 2
    • 33745351339 scopus 로고    scopus 로고
    • Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    • Ustun-Engin Y., Ustun Y., Meydanli{dotless} M.M., Kafkasli{dotless} A., and Yetkin G. Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?. Gynecol Endocrinol 22 (2006) 324-328
    • (2006) Gynecol Endocrinol , vol.22 , pp. 324-328
    • Ustun-Engin, Y.1    Ustun, Y.2    Meydanli, M.M.3    Kafkasli, A.4    Yetkin, G.5
  • 3
    • 19944433652 scopus 로고    scopus 로고
    • Visfatin: a protein secreted by visceral fat that mimics the effects of insulin
    • Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (2005) 426-430
    • (2005) Science , vol.307 , pp. 426-430
    • Fukuhara, A.1    Matsuda, M.2    Nishizawa, M.3    Segawa, K.4    Tanaka, M.5    Kishimoto, K.6
  • 4
    • 25844491778 scopus 로고    scopus 로고
    • Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
    • Berndt J., Kloting N., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
    • (2005) Diabetes , vol.54 , pp. 2911-2916
    • Berndt, J.1    Kloting, N.2    Kralisch, S.3    Kovacs, P.4    Fasshauer, M.5    Schon, M.R.6
  • 5
    • 30344471828 scopus 로고    scopus 로고
    • Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
    • Chen M.P., Chung F.M., Chang D.M., Tsai J.C.R., Huang H.-F., Shin S.J., et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 91 (2006) 295-299
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 295-299
    • Chen, M.P.1    Chung, F.M.2    Chang, D.M.3    Tsai, J.C.R.4    Huang, H.-F.5    Shin, S.J.6
  • 6
    • 33845476276 scopus 로고    scopus 로고
    • Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin
    • Tan B.K., Chen J., Digby J.E., Keay S.D., Kennedy C.R., and Randeva H.S. Increased visfatin messenger ribonucleic acid and protein levels in adipose tissue and adipocytes in women with polycystic ovary syndrome: parallel increase in plasma visfatin. J Clin Endocrinol Metab 91 (2006) 5022-5028
    • (2006) J Clin Endocrinol Metab , vol.91 , pp. 5022-5028
    • Tan, B.K.1    Chen, J.2    Digby, J.E.3    Keay, S.D.4    Kennedy, C.R.5    Randeva, H.S.6
  • 7
    • 34547672910 scopus 로고    scopus 로고
    • Increased plasma visfatin concentrations in women with polycystic ovary syndrome
    • Chan T.F., Chen Y.L., Chen H.H., Lee C.H., Jong S.B., and Tsai E.M. Increased plasma visfatin concentrations in women with polycystic ovary syndrome. Fertil Steril 88 (2007) 401-405
    • (2007) Fertil Steril , vol.88 , pp. 401-405
    • Chan, T.F.1    Chen, Y.L.2    Chen, H.H.3    Lee, C.H.4    Jong, S.B.5    Tsai, E.M.6
  • 8
    • 34447336403 scopus 로고    scopus 로고
    • Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome
    • Kowalska I., Straczkowsi M., Nikolajuk A., Adamska A., Karczewska-Kupczewska M., Otziomek E., et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 22 (2007) 1824-1829
    • (2007) Hum Reprod , vol.22 , pp. 1824-1829
    • Kowalska, I.1    Straczkowsi, M.2    Nikolajuk, A.3    Adamska, A.4    Karczewska-Kupczewska, M.5    Otziomek, E.6
  • 9
    • 0346725827 scopus 로고    scopus 로고
    • Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    • The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
    • (2004) Fertil Steril , vol.81 , pp. 19-25
  • 11
    • 0021813187 scopus 로고
    • Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
    • (1985) Diabetologia , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3    Naylor, B.A.4    Treacher, D.F.5    Turner, R.C.6
  • 12
    • 18644365016 scopus 로고    scopus 로고
    • Insulin resistance in type 2 diabetes-role of adipokines
    • Arner P. Insulin resistance in type 2 diabetes-role of adipokines. Curr Mol Med 5 (2005) 333-339
    • (2005) Curr Mol Med , vol.5 , pp. 333-339
    • Arner, P.1
  • 13
    • 0034075904 scopus 로고    scopus 로고
    • Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome
    • Sozen I., and Arici A. Hyperinsulinism and its interaction with hyperandrogenism in polycystic ovary syndrome. Obstet Gynecol Survey 55 (2000) 321-328
    • (2000) Obstet Gynecol Survey , vol.55 , pp. 321-328
    • Sozen, I.1    Arici, A.2
  • 15
    • 34147127510 scopus 로고    scopus 로고
    • Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance
    • Lewandowski K.C., Stojanovic N., Press M., Tuck S.M., Szosland K., Bienkiewicz M., et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 50 (2007) 1033-1037
    • (2007) Diabetologia , vol.50 , pp. 1033-1037
    • Lewandowski, K.C.1    Stojanovic, N.2    Press, M.3    Tuck, S.M.4    Szosland, K.5    Bienkiewicz, M.6
  • 16
    • 33745789837 scopus 로고    scopus 로고
    • The release of the adipocytokine visfatin is regulated by glucose and insulin
    • Haider D.G., Schaller G., Kapiotis S., Maier C., Luger A., and Wolzt M. The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 46 (2006) 1909-1914
    • (2006) Diabetologia , vol.46 , pp. 1909-1914
    • Haider, D.G.1    Schaller, G.2    Kapiotis, S.3    Maier, C.4    Luger, A.5    Wolzt, M.6
  • 17
    • 34347387742 scopus 로고    scopus 로고
    • Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus
    • Hsieh C.H., He C.T., Lee C.H., Wu L.Y., and Hung Y.J. Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus. Metabolism 56 (2007) 1087-1092
    • (2007) Metabolism , vol.56 , pp. 1087-1092
    • Hsieh, C.H.1    He, C.T.2    Lee, C.H.3    Wu, L.Y.4    Hung, Y.J.5
  • 18
    • 33947247655 scopus 로고    scopus 로고
    • Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus
    • Takebayashi K., Suetsugu M., Wakabayashi S., Aso Y., and Inukai T. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 56 (2007) 451-458
    • (2007) Metabolism , vol.56 , pp. 451-458
    • Takebayashi, K.1    Suetsugu, M.2    Wakabayashi, S.3    Aso, Y.4    Inukai, T.5
  • 19
    • 0034111902 scopus 로고    scopus 로고
    • Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome
    • Kolodziejczyk B., Duleba A.J., Spaczynski R.Z., and Pawelczyk L. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome. Fertil Steril 73 (2000) 1149-1154
    • (2000) Fertil Steril , vol.73 , pp. 1149-1154
    • Kolodziejczyk, B.1    Duleba, A.J.2    Spaczynski, R.Z.3    Pawelczyk, L.4
  • 20
    • 0031957333 scopus 로고    scopus 로고
    • Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome
    • Diamanti-Kandarakis E. Therapeutic effects of metformin on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Eur J Endocrinol 138 (1998) 269-274
    • (1998) Eur J Endocrinol , vol.138 , pp. 269-274
    • Diamanti-Kandarakis, E.1
  • 21
    • 34248593022 scopus 로고    scopus 로고
    • Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance
    • Nawrocka J., and Starczewski A. Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance. Gynecol Endocrinol 23 (2007) 231-237
    • (2007) Gynecol Endocrinol , vol.23 , pp. 231-237
    • Nawrocka, J.1    Starczewski, A.2
  • 22
    • 0142247208 scopus 로고    scopus 로고
    • Metformin in polycystic ovary syndrome: systematic review and meta-analysis
    • Lord J.M., Flight I.H., and Norman R.J. Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br Med J 327 (2003) 951-957
    • (2003) Br Med J , vol.327 , pp. 951-957
    • Lord, J.M.1    Flight, I.H.2    Norman, R.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.